On Wednesday, Shares of Broadcom Corp. (NASDAQ:BRCM), gained 5.00% to $46.18, hitting its highest level.
Broadcom Corporation, will be presenting at the following second quarter 2015 conferences:
- Robert W. Baird 2015 Growth Stock Conference, May 5, 2015, Four Seasons Hotel, Chicago. Broadcom’s presentation starts at 10:20 a.m. Central.
- P. Morgan TMT Conference, May 20, 2015, Westin Hotel, Boston. Broadcom’s presentation starts at 9:20 a.m. Eastern.
- Cowen and Company 43rd Annual TMT Conference, May 27, 2015, Palace Hotel, New York. Broadcom’s presentation starts at 2:45 p.m. Eastern.
- Bank of America Merrill Lynch Tech Conference, June 3, 2015, Ritz-Carlton Hotel, San Francisco. Broadcom’s presentation starts at 11:30 a.m. Pacific.
Broadcom Corporation provides semiconductor solutions for wired and wireless communications. Its products offer voice, video, data, and multimedia connectivity in the home, office, and mobile environments.
Shares of Rite Aid Corporation (NYSE:RAD), gained 4.92% to $8.32, during its last trading session.
Rite Aid Corporation, declared the appointment of Steve Rempel as the company’s senior vice president and chief information officer.
Rempel, a renowned IT veteran, will be reporting to Rite Aid’s senior executive vice president and chief administrative officer, Frank Vitrano. Further, in this role, Rempel will be responsible for the company’s overall technology and information operations, such as computer systems, data security, telecommunications and network infrastructure.
Preceding to his appointment by Rite Aid, Rempel worked with Balance Innovations as chief information officer, president and CEO. In that role, this able leader held responsibility for the company’s technology strategy, in addition to being actively involved in financial, planned and operational decisions.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products.
At the end of Wednesday’s trade, Shares of CTI BioPharma Corp. (NASDAQ:CTIC), gained 4.89% to $1.93.
CTI BioPharma, and Baxter International Inc. (BAX) recently declared that data from the randomized Phase 3 PERSIST-1 trial evaluating the investigational agent pacritinib in patients with myelofibrosis will be highlighted in a late-breaking oral presentation at the forthcoming American Society of Clinical Oncology (ASCO) 2015 Meeting (May 29-June 2, 2015 in Chicago, Ill). These data have also been selected as part of this year’s official ASCO press briefing – titled “Targeted Therapy” – to be held on Saturday, May 30, 2015 at 8:00 a.m. CT.
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.
Finally, Millennial Media Inc. (NYSE:MM), ended its last trade with 4.86% gain, and closed at $1.51.
Millennial Media, declared that it will hold its quarterly conference call to talk about its 2015 first quarter financial results on Tuesday, May 5, 2015 at 5:00 p.m. ET. President & Chief Executive Officer Michael Barrett will host the call. Millennial Media will release its 2015 first quarter financial results that day after market close.
Millennial Media, Inc. provides mobile advertising solutions to advertisers and developers in the United States and internationally. It offers advertisers the opportunity to reach and engage with their targeted audiences across mobile devices and screens; solutions that enables advertisers to gain insights into the performance of their ad campaigns and to manage their campaigns; and cross-screen device map that allows to associate a single user with multiple online and mobile devices.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
